Managed Care e-News
May. 14, 2013

Cautious optimism healthcare spending growth has slowed
United Press International
U.S. researchers say they are cautiously optimistic the slowdown in healthcare spending is here to stay. Professor Michael Chernew, medical student Alexander Ryu, lecturer Teresa B. Gibson and research associate M. Richard McKellar, all of the Harvard Medical School in Boston, say national health expenditures grew exceptionally slowly during and immediately after the recent recession. More

Budget request denied, HHS turns to health executives to finance Obamacare
The Washington Post
Health and Human Services Secretary Kathleen Sebelius has gone, hat in hand, to health industry officials, asking them to make large financial donations to help with the effort to implement President Obama’s landmark healthcare law, two people familiar with the outreach said.More

Study: Cuts to Medicare trim costs to insurers
Politico
When Medicare payment rates for hospital inpatient care are cut, do insurers end up paying more? A new study published in Health Affairs finds they don't — contradicting the well-known "cost shifting" theory. More

Hospitals get more revenue from primary care docs than specialists
FierceHealthcare
Primary care physicians generate more revenue for their hospitals than specialists — $1.57 million versus $1.42 million, respectively — according to a report from recruiting firm Merritt Hawkins.More

FDA proposes new tanning bed warnings
TIME
If the FDA gets its way, tanning beds may soon feature labels warning young people to steer clear of the machines and their jolts of UV radiation.More

Flu during pregnancy may raise bipolar risk for baby
Fox News
If expectant mothers catch the flu during pregnancy, their babies could be four times as likely to develop bipolar disorder later in life, BBC News reported. More

Blocking a single gene renders tumors less aggressive
Medical News Today
Researchers at Johns Hopkins have identified a gene that, when repressed in tumor cells, puts a halt to cell growth and a range of processes needed for tumors to enlarge and spread to distant sites. The researchers hope that this so-called "master regulator" gene may be the key to developing a new treatment for tumors resistant to current drugs. More

Birthmark has genetic ties to neural syndrome
MedPage Today
The same genetic mutation causes uncomplicated port-wine stains and Sturge-Weber syndrome, which is characterized by the same staining plus leptomeningeal vascular abnormalities, researchers reported.More

Use of theranostic nanoparticles nanoparticles for cancer treatment drugs
By Archita Datta Majumdar
n ongoing global research for combating cancer, new theories constantly surface to fuel newer dimensions of treatment and therapy. Perhaps none has generated as much hope as the latest theory of using nanoparticles to create new-age cancer drugs.More

Medicare revises readmissions penalties — Again
Kaiser Health News
In its effort to crack down on repeat hospitalizations, Medicare has its own readmission: for the second time in six months, it has erred in calculating penalties for more than 1,000 of the nation’s hospitals.More

Hospital execs project shift to outpatient care, more HIT spending
FierceHealthcare
Only about a third of hospital and practice executives think inpatient admissions will increase this year, a new survey shows, down 30 percent from a year ago.More

Use of theranostic nanoparticles nanoparticles for cancer treatment drugs
By Archita Datta Majumdar
In ongoing global research for combating cancer, new theories constantly surface to fuel newer dimensions of treatment and therapy. Perhaps none has generated as much hope as the latest theory of using nanoparticles to create new-age cancer drugs. A recent study by Swedish scientists reveals the possibilities hitherto unthought of — effective delivery of cancer drugs to the tumor cells through "theranostic nanoparticles," a method that combines therapy and diagnostics in one single nanomaterial.More

Odds against Congress restoring cancer drug funding
Roll Call
Lawmakers and outside coalitions supported by doctors and drug companies face an uphill battle in their bid to reverse sequester cuts that have hit cancer drugs.More

Eating peppers may lower Parkinson's risk
MyHealthNewDaily
Regularly eating peppers may lower the risk of Parkinson's disease, a new study suggests. The researchers said the benefit may be due to a substance in the vegetable that we've been advised to avoid: nicotine. People in the study who ate peppers two times per week were 30 percent less likely to develop Parkinson's disease than people who ate peppers less than once a week.More

Hypertension drug works for schizophrenia
MedPage Today
Psychotic patients improved rapidly after a single infusion of sodium nitroprusside, researchers reported. In a small randomized trial, patients who got the antihypertensive agent saw most of their symptoms diminish within four hours, while those who got a matching placebo did not, according to researchers.More